Prophylaxis strategy prevents perinatal HBV transmission

Prophylaxis strategy prevents perinatal HBV transmission

(HealthDay)—Prenatal screening followed by immunoprophylaxis for infants of mothers with chronic hepatitis B virus (HBV) infection decreases perinatal transmission, according to research published online May 27 in the Annals of Internal Medicine.

Ai Kubo, Ph.D., of Kaiser Permanente in Oakland, Calif., and colleagues conducted an observational study of 4,446 infants born to 3,253 HBV-positive mothers. The authors sought to assess the efficacy of an immunoprophylaxis program.

The researchers found that the infant HBV per 100 births were 3.37 (95 percent confidence interval [CI], 2.08 to 5.14) for e antigen-positive mothers and 0.04 (95 percent CI, 0.001 to 0.24) for e antigen-negative mothers. Among mothers who received testing, the lowest viral load level associated with transmission of HBV was 6.32 × 107 IU/mL. Infection rates per 100 births were 3.61 (95 percent CI, 0.75 to 10.56) among mothers with of 5 × 107 IU/mL or greater (83 births) and 0 among with viral loads less than 5 × 107 IU/mL (831 births), regardless of e antigen status.

"A negative e antigen status or a viral load less than 5 × 107 IU/mL (90.9 percent of women tested) identifies women at extremely low risk for transmission after immunoprophylaxis who are unlikely to benefit from further interventions," the authors write.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

5 things to know about Ebola outbreak in W. Africa

12 hours ago

(AP)—There has been panic and fear about the deadly Ebola disease spreading ever since Nigerian health officials reported Friday that a Liberian man sick with the disease had traveled to Togo and then Nigeria ...

Scissoring the lipids

13 hours ago

A new strategy which enables molecules to be disconnected essentially anywhere, even remote from functionality, is described by researchers from the University of Bristol in Nature Chemistry today. The method is now being ...

User comments